Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

33 in total

Review 1. Degarelix: a review of its use in patients with prostate cancer.

Authors: Natalie J Carter; Susan J Keam
Journal: Drugs Date: 2014-04 Impact factor: 9.546

Review 2. Androgen deprivation therapy in the treatment of locally advanced, nonmetastatic prostate cancer: practical experience and a review of the clinical trial evidence.

Authors: Fouad Aoun; Ali Bourgi; Elias Ayoub; Elie El Rassy; Roland van Velthoven; Alexandre Peltier
Journal: Ther Adv Urol Date: 2017-03-01

Review 3. Imaging and evaluation of patients with high-risk prostate cancer.

Authors: Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal: Nat Rev Urol Date: 2015-10-20 Impact factor: 14.432

4. In reply.

Authors: Axel S Merseburger; Joaquim Bellmunt; Cheryl Jenkins; Chris Parker; John M Fitzpatrick
Journal: Oncologist Date: 2014-02-17

5. Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

Authors: Zachary D Nagel; Isaac A Chaim; Leona D Samson
Journal: DNA Repair (Amst) Date: 2014-04-26

Review 6. Bisphosphonates for advanced prostate cancer.

Authors: Sascha Macherey; Ina Monsef; Franziska Jahn; Karin Jordan; Kwok Keung Yuen; Axel Heidenreich; Nicole Skoetz
Journal: Cochrane Database Syst Rev Date: 2017-12-26

7. Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.

Authors: M Joerger; C Schaer-Thuer; D Koeberle; K Matter-Walstra; J Gibbons-Marsico; S Diem; B Thuerlimann; T Cerny
Journal: Eur J Clin Pharmacol Date: 2014-03-11 Impact factor: 2.953

8. Conversion to monotherapy with luteinizing-hormone releasing hormone agonist or orchiectomy after reaching PSA nadir following maximal androgen blockade is able to prolong progression-free survival in patients with metastatic prostate cancer: A propensity score matching analysis.

Authors: Gyeong Eun Min; Hanjong Ahn
Journal: Oncol Lett Date: 2017-04-20 Impact factor: 2.967

Review 9. Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors: Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal: Eur J Nucl Med Mol Imaging Date: 2016-03-09 Impact factor: 9.236

Review 10. Prostasomes as a source of diagnostic biomarkers for prostate cancer.

Authors: Carla Zijlstra; Willem Stoorvogel
Journal: J Clin Invest Date: 2016-04-01 Impact factor: 14.808